Argatroban

Argatroban

Catalog Number:
MAR1341482TOK
Mfr. No.:
TOK-A171
Price:
$229
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Argatroban is a synthetic small molecule and potent thrombin inhibitor that functions as an anticoagulant agent. It can protect against thrombosis by limiting clot formation.

          Please contact us at for specific academic pricing.

          Background

          Argatroban is able to inhibit thrombin directly and univalently. The Ki values against thrombin range from 5 nM to 39 nM.

      • Properties
        • Categories
          BioActive Small Molecules
          CAS Number
          74863-84-6
          Molecular Formula
          C23H36N6O5S
          Molecular Weight
          508.63
          Appearance
          White to off-white crystalline powder
          Solubility
          Slightly soluble in methanol, ethanol, DMF and DMSO.
          Other Properties
          Source: Synthetic
          Purity Level: ≥98% (anhydrous basis)
          Storage
          -20°C

          * For research use only

      • Applications
        • Application Description
          Eukaryotic Cell Culture Applications: Argatroban was applied to cultured rabbit aortic vascular smooth muscle cells, and the expression of myosin heavy-chain isoform mRNAs was evaluated. Authors found mRNA was homogenously expressed, thus inducing the phenotypic conversion of vascular smooth muscle cells (Yoshinaga et al, 2003). The effect of Argatroban on endothelial cells experimentall injured by thrombin were investigated using cell line TKM-33 cloned from human umbilical vein endothelial cells. Endothelial cells make plasminogen activator to maintain blood flow and prevent thrombosis. The treatment with Argatroban prior to thrombin injury resulted in the induction of plasminogen activator inhibitor-1 (PAI-1) secretion. Thus, Argatroban pretreatment can prevent thrombin injury of endothelial cells (Ueshima et al, 2000).

          Cancer Applications: Argatroban was found to reduce breast cancer malignancy and metastatis in MDA-MB-468 human breast cancer cells that were stably transfected to overexpress osteopontin. Argatroban treatment of 25 µg/ml resulted in decreased cell growth, colony-forming ability, adhesion, and migration (Schulze et al, 2008).

    Note: If you don't receive our verification email, do the following:

  • Copyright © Amerigo Scientific. All rights reserved.